Stockscreener 앱 받기
20.05
1.99%
-0.49
전일 마감가:
$20.54
열려 있는:
$19.86
하루 거래량:
353.31K
Relative Volume:
0.80
시가총액:
$571.94M
수익:
$290.71M
순이익/손실:
$-163.43M
주가수익비율:
-3.6588
EPS:
-5.48
순현금흐름:
$11.70M
1주 성능:
+8.64%
1개월 성능:
+19.40%
6개월 성능:
-8.62%
1년 성능:
-6.36%
1일 변동 폭
$19.25
$20.43
1주일 범위
$17.02
$20.94
52주 변동 폭
$14.76
$25.11
Fulgent Genetics Inc Stock (FLGT) Company Profile
명칭
Fulgent Genetics Inc
전화
626-350-0537
주소
4399 SANTA ANITA AVE, EL MONTE
FLGT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
20.07 | 571.94M | 290.71M | -163.43M | 11.70M | -5.48 |
|
TMO
Thermo Fisher Scientific Inc
|
422.90 | 159.05B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
198.93 | 140.21B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
480.06 | 35.17B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
109.07 | 30.47B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
153.85 | 26.47B | 15.41B | 1.37B | 2.11B | 7.50 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-07 | 개시 | UBS | Neutral |
| 2022-12-08 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-11-18 | 개시 | Raymond James | Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-02-04 | 재개 | Piper Sandler | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Underperform |
| 2021-01-08 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2020-11-24 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-08-20 | 개시 | Oppenheimer | Outperform |
| 2020-05-29 | 개시 | BTIG Research | Buy |
| 2019-11-05 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2018-03-01 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-11-07 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
모두보기
Fulgent Genetics Inc 주식(FLGT)의 최신 뉴스
Fulgent Genetics (FLGT) Target Price Raised by Raymond James | FLGT Stock News - GuruFocus
Fulgent Genetics (NASDAQ:FLGT) Posts Quarterly Earnings Results, Beats Estimates By $0.22 EPS - MarketBeat
Fulgent Genetics (FLGT) Sees Increased Price Target Following Strong Q1 Performance | FLGT Stock News - GuruFocus
Fulgent revenue up 16% to USD 73.5M in Q1 2025 - Medical Buyer
Is Fulgent Genetics (NASDAQ:FLGT) Using Too Much Debt? - simplywall.st
Fulgent Genetics (NASDAQ:FLGT) Shares Gap UpHere's What Happened - MarketBeat
Park West Asset Management LLC Cuts Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Releases FY 2025 Earnings Guidance - MarketBeat
Almitas Capital LLC Invests $296,000 in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Renaissance Technologies LLC Reduces Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Nebula Research & Development LLC Takes Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2025 Earnings Call Transcript - Insider Monkey
Fulgent Genetics Inc (FLGT) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges - Yahoo Finance
Fulgent Genetics Inc (FLGT) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges By GuruFocus - Investing.com Canada
Fulgent Genetics Reports Strong Q1 2025 Growth - TipRanks
Fulgent Genetics earnings beat by $0.12, revenue fell short of estimates - Investing.com Canada
Fulgent Genetics Q1 2025 Earnings: Revenue Surpasses Estimates a - GuruFocus
Fulgent Genetics (FLGT) Q1 Earnings Surpass Expectations - GuruFocus
Fulgent Genetics (FLGT) Stock Surges After Strong Q1 Results - GuruFocus
Fulgent Genetics rises on earnings, revenue beat - MSN
Earnings call transcript: Fulgent Genetics Q1 2025 beats EPS forecast, stock rises - Investing.com
Press Release Distribution & PR Platform - ACCESS Newswire
Fulgent Genetics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Fulgent Genetics, Inc. Reiterates Earnings Guidance for the Fiscal Year 2025 - marketscreener.com
Fulgent Genetics, Inc. (FLGT) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
FLGT Reiterates 2025 Revenue Outlook Amid Strong Start | FLGT St - GuruFocus
Fulgent Reports First Quarter 2025 Financial Results | FLGT Stoc - GuruFocus
Fulgent Reports First Quarter 2025 Financial Results - BioSpace
A significant driver of top-line growth: Fulgent Genetics Inc (FLGT) - Sete News
Fulgent Genetics Q1 2025 Earnings: Revenue Surpasses Estimates at $73.5M, GAAP EPS Misses with $0.37 Loss - GuruFocus
Fulgent Genetics Reports Strong Q1 2025 Financial Results - TipRanks
Fulgent Genetics, Inc. SEC 10-Q Report - TradingView
Fulgent Reports First Quarter 2025 Financial Results | FLGT Stock News - GuruFocus
Invesco Ltd. Has $3.36 Million Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Investor Network: Fulgent Genetics, Inc. to Host Earnings Call - ACCESS Newswire
A Peek at Fulgent Genetics's Future Earnings - Nasdaq
Fulgent Genetics Inc [FLGT] Shares Fall Approximately -13.68% Over the Year - knoxdaily.com
Closing Figures Unveiled: Fulgent Genetics Inc (FLGT) Drop -4.30, Closes at 17.35 - DWinneX
Syon Capital LLC Makes New Investment in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Fulgent Genetics (FLGT) Expected to Announce Earnings on Friday - Defense World
Fulgent Genetics (FLGT) Projected to Post Earnings on Friday - MarketBeat
Jump Financial LLC Takes Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Geode Capital Management LLC Grows Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Fulgent Genetics Inc (FLGT) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
Fulgent Genetics Inc (FLGT) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic Investments - GuruFocus
JPMorgan Chase & Co. Raises Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Vanguard Group Inc. Decreases Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Inlight Wealth Management LLC Purchases New Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Vanguard Group Inc. Has $25.69 Million Stock Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
ExodusPoint Capital Management LP Purchases 39,618 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Fulgent Genetics Inc (FLGT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
0.08%
자본화:
|
볼륨(24시간):